NCLEX Pharmacology Practice Exam Fall
Semester 2026 | 200+ Verified Questions &
Rationales Study Guide
NCLEX PHARMACOLOGY PRACTICE EXAM
Fall Semester 2026 | 200+ Verified Questions & RATIONALE
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━━━━
Q1. A patient receives a drug with a half-life of 8 hours. Approximately how long
will it take for the drug to reach steady-state plasma concentration with regular
dosing?
A. 8 hours
B. 16 hours
C. 24 hours
D. 40 hours
E. 64 hours
CORRECT ANSWER: D. 40 hours
RATIONALE: Steady-state is reached after approximately 4–5 half-lives. With a
half-life of 8 hours: 5 × 8 = 40 hours. At steady-state, the rate of drug administration
equals the rate of elimination, maintaining a consistent therapeutic level.
Q2. A nurse is reviewing a drug that undergoes extensive first-pass metabolism.
Which route of administration would BEST bypass this effect?
A. Oral
B. Rectal
C. Sublingual
D. Enteral via NG tube
E. Buccal via swallowed tablet
CORRECT ANSWER: C. Sublingual
, RATIONALE: The sublingual route allows drugs to be absorbed directly into the
systemic circulation via the sublingual veins, completely bypassing the portal circulation
and first-pass hepatic metabolism. This is why nitroglycerin is administered sublingually
for rapid effect.
Q3. A patient with severe liver cirrhosis is prescribed a drug that is 95% protein-
bound. Which pharmacokinetic change is MOST expected?
A. Decreased volume of distribution
B. Increased renal clearance of the drug
C. Increased free drug concentration and toxicity risk
D. Decreased drug half-life
E. Enhanced first-pass metabolism
CORRECT ANSWER: C. Increased free drug concentration and toxicity risk
RATIONALE: The liver produces albumin. In liver cirrhosis, albumin levels are
reduced, meaning fewer binding sites are available for highly protein-bound drugs. This
results in more free (unbound) drug in the circulation, increasing the risk of drug toxicity
even at standard doses.
Q4. A drug is described as having zero-order kinetics. What does this mean
clinically?
A. The drug is eliminated at a rate proportional to its concentration
B. A constant amount of drug is eliminated per unit time regardless of concentration
C. The drug reaches steady state after two half-lives
D. The drug is only eliminated by renal excretion
E. The drug has a predictable and linear dose-response relationship
CORRECT ANSWER: B. A constant amount of drug is eliminated per unit time
regardless of concentration
RATIONALE: Zero-order kinetics (saturation kinetics) means that metabolic
enzymes are saturated, and a fixed amount of drug is metabolized per unit time. This
makes these drugs dangerous as small dose increases can cause disproportionately
,large rises in plasma levels. Classic examples include ethanol, phenytoin, and aspirin at
high doses.
Q5. A nurse administers a drug with a narrow therapeutic index. Which nursing
action is MOST critical?
A. Administer the drug with food to increase absorption
B. Monitor serum drug levels and assess for signs of toxicity frequently
C. Administer the drug intramuscularly to reduce variability
D. Double the dose if the patient misses a scheduled dose
E. Switch to an equivalent generic formulation without physician order
CORRECT ANSWER: B. Monitor serum drug levels and assess for signs of
toxicity frequently
RATIONALE: A narrow therapeutic index (NTI) drug has a small difference
between therapeutic and toxic doses. Examples include warfarin, digoxin, lithium, and
phenytoin. Frequent monitoring of serum levels and clinical toxicity signs is paramount
to prevent serious adverse events.
Q6. Which pharmacodynamic concept describes a situation where two drugs
together produce an effect GREATER than the sum of their individual effects?
A. Antagonism
B. Additive effect
C. Synergism
D. Tolerance
E. Tachyphylaxis
CORRECT ANSWER: C. Synergism
RATIONALE: Synergism (potentiation) occurs when two drugs produce an effect
greater than the sum of their individual effects (e.g., 1+1=3). This is different from an
additive effect where 1+1=2. An example is the combined use of beta-lactam antibiotics
with aminoglycosides for enhanced bactericidal activity.
, Q7. A patient taking phenytoin for seizures is started on rifampin for tuberculosis.
The nurse should monitor for which effect?
A. Phenytoin toxicity due to increased plasma levels
B. Seizure recurrence due to decreased phenytoin levels
C. Rifampin toxicity due to phenytoin inhibition
D. Additive sedation from both medications
E. Increased risk of bleeding due to drug interaction
CORRECT ANSWER: B. Seizure recurrence due to decreased phenytoin levels
RATIONALE: Rifampin is a potent inducer of cytochrome P450 enzymes
(CYP450), particularly CYP2C9 and CYP3A4. It accelerates the metabolism of
phenytoin, significantly reducing its plasma concentration and potentially causing loss of
seizure control. Dose adjustment of phenytoin is required.
Q8. A patient is given a competitive antagonist along with an agonist. What
happens to the dose-response curve of the agonist?
A. The curve shifts to the left with a decreased maximum effect
B. The curve shifts to the right with the same maximum effect
C. The curve shifts to the right with a decreased maximum effect
D. The curve shifts to the left with an increased maximum effect
E. The curve remains unchanged
CORRECT ANSWER: B. The curve shifts to the right with the same maximum
effect
RATIONALE: A competitive antagonist competes reversibly with the agonist at the
same receptor site. Increasing the dose of the agonist can overcome this competition.
Therefore, the dose-response curve shifts to the right (requires more agonist to achieve
the same effect), but the maximum effect (Emax) remains the same.
Q9. A patient with chronic kidney disease (CKD Stage 4) is prescribed a
medication that is 80% renally excreted. What pharmacokinetic change is MOST
expected?
Semester 2026 | 200+ Verified Questions &
Rationales Study Guide
NCLEX PHARMACOLOGY PRACTICE EXAM
Fall Semester 2026 | 200+ Verified Questions & RATIONALE
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
━━━━━━━━━
Q1. A patient receives a drug with a half-life of 8 hours. Approximately how long
will it take for the drug to reach steady-state plasma concentration with regular
dosing?
A. 8 hours
B. 16 hours
C. 24 hours
D. 40 hours
E. 64 hours
CORRECT ANSWER: D. 40 hours
RATIONALE: Steady-state is reached after approximately 4–5 half-lives. With a
half-life of 8 hours: 5 × 8 = 40 hours. At steady-state, the rate of drug administration
equals the rate of elimination, maintaining a consistent therapeutic level.
Q2. A nurse is reviewing a drug that undergoes extensive first-pass metabolism.
Which route of administration would BEST bypass this effect?
A. Oral
B. Rectal
C. Sublingual
D. Enteral via NG tube
E. Buccal via swallowed tablet
CORRECT ANSWER: C. Sublingual
, RATIONALE: The sublingual route allows drugs to be absorbed directly into the
systemic circulation via the sublingual veins, completely bypassing the portal circulation
and first-pass hepatic metabolism. This is why nitroglycerin is administered sublingually
for rapid effect.
Q3. A patient with severe liver cirrhosis is prescribed a drug that is 95% protein-
bound. Which pharmacokinetic change is MOST expected?
A. Decreased volume of distribution
B. Increased renal clearance of the drug
C. Increased free drug concentration and toxicity risk
D. Decreased drug half-life
E. Enhanced first-pass metabolism
CORRECT ANSWER: C. Increased free drug concentration and toxicity risk
RATIONALE: The liver produces albumin. In liver cirrhosis, albumin levels are
reduced, meaning fewer binding sites are available for highly protein-bound drugs. This
results in more free (unbound) drug in the circulation, increasing the risk of drug toxicity
even at standard doses.
Q4. A drug is described as having zero-order kinetics. What does this mean
clinically?
A. The drug is eliminated at a rate proportional to its concentration
B. A constant amount of drug is eliminated per unit time regardless of concentration
C. The drug reaches steady state after two half-lives
D. The drug is only eliminated by renal excretion
E. The drug has a predictable and linear dose-response relationship
CORRECT ANSWER: B. A constant amount of drug is eliminated per unit time
regardless of concentration
RATIONALE: Zero-order kinetics (saturation kinetics) means that metabolic
enzymes are saturated, and a fixed amount of drug is metabolized per unit time. This
makes these drugs dangerous as small dose increases can cause disproportionately
,large rises in plasma levels. Classic examples include ethanol, phenytoin, and aspirin at
high doses.
Q5. A nurse administers a drug with a narrow therapeutic index. Which nursing
action is MOST critical?
A. Administer the drug with food to increase absorption
B. Monitor serum drug levels and assess for signs of toxicity frequently
C. Administer the drug intramuscularly to reduce variability
D. Double the dose if the patient misses a scheduled dose
E. Switch to an equivalent generic formulation without physician order
CORRECT ANSWER: B. Monitor serum drug levels and assess for signs of
toxicity frequently
RATIONALE: A narrow therapeutic index (NTI) drug has a small difference
between therapeutic and toxic doses. Examples include warfarin, digoxin, lithium, and
phenytoin. Frequent monitoring of serum levels and clinical toxicity signs is paramount
to prevent serious adverse events.
Q6. Which pharmacodynamic concept describes a situation where two drugs
together produce an effect GREATER than the sum of their individual effects?
A. Antagonism
B. Additive effect
C. Synergism
D. Tolerance
E. Tachyphylaxis
CORRECT ANSWER: C. Synergism
RATIONALE: Synergism (potentiation) occurs when two drugs produce an effect
greater than the sum of their individual effects (e.g., 1+1=3). This is different from an
additive effect where 1+1=2. An example is the combined use of beta-lactam antibiotics
with aminoglycosides for enhanced bactericidal activity.
, Q7. A patient taking phenytoin for seizures is started on rifampin for tuberculosis.
The nurse should monitor for which effect?
A. Phenytoin toxicity due to increased plasma levels
B. Seizure recurrence due to decreased phenytoin levels
C. Rifampin toxicity due to phenytoin inhibition
D. Additive sedation from both medications
E. Increased risk of bleeding due to drug interaction
CORRECT ANSWER: B. Seizure recurrence due to decreased phenytoin levels
RATIONALE: Rifampin is a potent inducer of cytochrome P450 enzymes
(CYP450), particularly CYP2C9 and CYP3A4. It accelerates the metabolism of
phenytoin, significantly reducing its plasma concentration and potentially causing loss of
seizure control. Dose adjustment of phenytoin is required.
Q8. A patient is given a competitive antagonist along with an agonist. What
happens to the dose-response curve of the agonist?
A. The curve shifts to the left with a decreased maximum effect
B. The curve shifts to the right with the same maximum effect
C. The curve shifts to the right with a decreased maximum effect
D. The curve shifts to the left with an increased maximum effect
E. The curve remains unchanged
CORRECT ANSWER: B. The curve shifts to the right with the same maximum
effect
RATIONALE: A competitive antagonist competes reversibly with the agonist at the
same receptor site. Increasing the dose of the agonist can overcome this competition.
Therefore, the dose-response curve shifts to the right (requires more agonist to achieve
the same effect), but the maximum effect (Emax) remains the same.
Q9. A patient with chronic kidney disease (CKD Stage 4) is prescribed a
medication that is 80% renally excreted. What pharmacokinetic change is MOST
expected?
